ADPRS Gene (ADP-Ribosylserine Hydrolase)

Key regulator of ADP-ribosylation dynamics in DNA damage repair and cellular stress responses

Gene Information Card

Symbol ADPRS
Full Name ADP-ribosylserine hydrolase
Gene Type Protein coding
Chromosomal Location 1p36.13
NCBI Gene ID 54936 ncbi.nlm.nih.gov/gene/54936
Ensembl ID ENSG00000117525
UniProt ID Q9NX46
OMIM ID 618170
HGNC ID 25134
Aliases ADPRHL2, ARH3, ADPRS1

Description

The ADPRS gene encodes ADP-ribosylserine hydrolase (ARH3), an enzyme that specifically hydrolyzes ADP-ribosylserine linkages, reversing serine ADP-ribosylation. This activity is critical for regulating ADP-ribosylation dynamics during DNA damage repair, chromatin remodeling, and cellular stress responses. ADPRS is involved in the removal of poly(ADP-ribose) from proteins, thereby modulating PARP-dependent signaling pathways. Mutations in ADPRS have been linked to neurodegenerative disorders and cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neurodegeneration with ataxia and spasticity (NEDCAS) Loss-of-function mutations impair ADP-ribosylserine hydrolysis, leading to accumulation of ADP-ribosylated proteins and neuronal dysfunction ClinVar, OMIM
Breast cancer Altered ADPRS expression may affect DNA repair capacity and PARP inhibitor sensitivity COSMIC, NCBI Gene
Ovarian cancer Somatic mutations and copy number alterations observed in tumor samples COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Low
Liver 6.1 Low
Kidney 9.7 Low
Testis 15.2 Medium
Lung 7.4 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 14.8 Embryonic kidney cells
HeLa 11.2 Cervical cancer cells
K562 9.5 Leukemia cells
SH-SY5Y 16.3 Neuroblastoma cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.430C>T (p.Arg144Trp) Missense Rare Loss of hydrolase activity; associated with NEDCAS
c.694G>A (p.Gly232Arg) Missense Rare Reduced protein stability and enzymatic function
c.1003C>T (p.Arg335*) Nonsense Rare Premature truncation; loss of function
Mutation functional classification

Loss of Function (LOF)

Missense and nonsense mutations that reduce or abolish ADP-ribosylserine hydrolase activity, leading to accumulation of ADP-ribosylated proteins and cellular dysfunction.

Gain of Function (GOF)

No gain-of-function mutations have been reported for ADPRS.

Dominant Negative (DN)

No dominant-negative mutations have been characterized for ADPRS.

Gene Ontology (GO)

• GO:0000287 magnesium ion binding • GO:0003824 catalytic activity
• GO:0003950 ADP-ribosylarginine hydrolase activity • GO:0005634 nucleus
• GO:0005737 cytoplasm • GO:0006281 DNA repair
• GO:0016787 hydrolase activity • GO:0035609 ADP-ribosylserine hydrolase activity
• GO:0070213 protein ADP-ribosylation

Pathways

ADP-ribosylation and reversal (Reactome: R-HSA-6814756)
DNA damage response (Reactome: R-HSA-73894)
Metabolism of proteins (Reactome: R-HSA-392499)

Protein Summary

ADP-ribosylserine hydrolase (ARH3) is a 363-amino acid protein that belongs to the ADP-ribosylglycohydrolase family. It contains a conserved macrodomain fold and requires magnesium ions for catalytic activity. ARH3 specifically cleaves ADP-ribose from serine residues, reversing serine ADP-ribosylation. The protein is localized to both the nucleus and cytoplasm, where it participates in DNA repair and stress signaling. Structural studies reveal a deep catalytic cleft that accommodates the ADP-ribose moiety. ARH3 is essential for maintaining cellular ADP-ribosylation homeostasis and preventing neurodegeneration.

Related Products

Product name Cat.No. Species Gene ID
ADPRS Knockout HEK293 Cell Line EDJ-KQ12297 Human 54936 Details Get a Quote
ADPRS Knockout HCT 116 Cell Line EDJ-KQ41110 Human 54936 Details Get a Quote
ADPRS Knockout HeLa Cell Line EDJ-KQ41111 Human 54936 Details Get a Quote
ADPRS Knockout A-549 Cell Line EDJ-KQ39861 Human 54936 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: